Recently Viewed

  • Home
  • Stories
  • News Announcement
  • 3B BlackBio Dx: Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2026.
News Announcement

3B BlackBio Dx: Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2026.

05-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF 3B Blackbio Dx

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended 30th June 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan